A groundbreaking imaging technique has, for the first time, made the invisible visible. For the first time, scientists have ...

The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.

IND submitted to FDA and HREC approval obtained in Australia; global trial initiation in Q4 2025 HUNTSVILLE, AL, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: ...

Serina Therapeutics ( ($SER) ) has provided an update. On October 6, 2025, Serina Therapeutics announced the receipt of the first $5 million ...

Personalized, at-home, adaptive deep brain stimulation is safe and effective for patients with moderate-to-advanced Parkinson’s disease, new data show.

A hallmark of Parkinson’s is the presence of abnormal protein clumps, known as Lewy bodies, in the brain. However, some ...

The study claims to be the first in the world to combine AI and optogenetics in Parkinson’s diagnosis and treatment.

The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple ...

Researchers discovered Human Pegivirus in brain tissue from five of ten Parkinson's patients, suggesting the virus may play a ...

Landmark partnership with Bahrain Specialist Hospital brings world-class Parkinson’s and dementia care closer to patients ...

Researchers analyzed data from over 222,000 Parkinson's patients and found TCE exposure from metal degreasing and industrial ...